Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
International Journal of Molecular Sciences|September 28, 2021
Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid LeukemiaThomas Cluzeau, Michael Loschi, Pierre Fenaux, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 22, 2021
Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex KaryotypeClemence Marcault, Nicolas Boissel, Claudia Haferlach, et al.
Cellular & Molecular Biology Letters|January 26, 2025
VEXAS, Chediak-Higashi syndrome and Danon disease: myeloid cell endo-lysosomal pathway dysfunction as a common denominator?Coline Savy, Maxence Bourgoin, Thomas Cluzeau, et al.
Annals of Hematology|August 18, 2015
Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphomaAmandine Segot, Emmanuel Raffoux, Etienne Lengline, et al.
Haematologica|March 25, 2014
Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemiaDelphine Rea, Tristan Mirault, Thomas Cluzeau, et al.
Cell Cycle (Georgetown, Tex.)|June 10, 2011
Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagyThomas Cluzeau, Guillaume Robert, Alexandre Puissant, et al.
Antimicrobial Resistance and Infection Control|January 17, 2024
Efficacy of an antimicrobial stewardship intervention for early adaptation of antibiotic therapy in high-risk neutropenic patientsClaire Durand, Karine Risso, Michael Loschi, et al.
Bone Marrow Transplantation|January 9, 2022
Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case reportMichael Loschi, Christian Roux, Isabelle Sudaka, et al.
Blood Neoplasia|January 23, 2026
Adapted physical activity for hematology inpatients: focus on lean mass gainAxel Sudria, Michael Loschi, Andrea Pinto, et al.
European Journal of Haematology|May 6, 2015
Novel fusion between the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with chronic myeloid leukemia-like neoplasm: undetectable residual disease after imatinib therapyThomas Cluzeau, Eric Lippert, Jean-Michel Cayuela, et al.
Pageof 13